Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Artiva Biotherapeutics, Inc. (ARTV)

Bush Jennifer — COO, CLO, Compliance Officer
Oct 5, 2026
Sale
Shares
8,370
Price
$6.84
Total Value
$57.23K
Shares Held After
366,159
% of Holdings
2.2%

Monte Rosa Therapeutics, Inc. (GLUE)

Bowen Matthew — Principal Accounting Officer
Oct 5, 2026
Sale
Shares
13
Price
$10.56
Total Value
$137.28
Shares Held After
25,891
% of Holdings
0.1%
Oct 5, 2026
Purchase
Shares
648,455
Price
$7.51
Total Value
$4.87M
Shares Held After
12,778,380
% of Holdings
5.1%
Oct 5, 2026
Sale
Shares
5,182
Price
$29.67
Total Value
$153.75K
Shares Held After
377,802
% of Holdings
1.4%
Oct 5, 2026
Sale
Shares
6,699
Price
$28.82
Total Value
$193.07K
Shares Held After
382,984
% of Holdings
1.7%

CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV)

Reynoso Jamie L. — CEO, Medicare Advantage
Oct 5, 2026
Sale
Shares
8,750
Price
$4.42
Total Value
$38.67K
Shares Held After
2,794,696
% of Holdings
0.3%
Oct 5, 2026
Purchase
Shares
1,694
Price
$2.06
Total Value
$3.49K
Shares Held After
2,858,657
% of Holdings
0.1%
Oct 5, 2026
Purchase
Shares
18,182
Price
$1.33
Total Value
$24.18K
Shares Held After
935,021
% of Holdings
1.9%

Royalty Pharma plc (RPRX)

Urist Marshall — EVP, Research&Investments
Oct 5, 2026
Sale
Shares
4,126
Price
$57.10
Total Value
$235.59K
Shares Held After
0
% of Holdings
100.0%

Medline Inc. (MDLN)

GIC Private Ltd — 10% Owner
Oct 2, 2026
Sale
Shares
7,146,941
Price
$34.33
Total Value
$245.35M
Shares Held After
84,408,506
% of Holdings
7.8%

Medline Inc. (MDLN)

GIC Private Ltd — 10% Owner
Oct 2, 2026
Sale
Shares
2,570,999
Price
$35.35
Total Value
$90.88M
Shares Held After
20,231,483
% of Holdings
11.3%

SI-BONE, Inc. (SIBN)

PISETSKY MICHAEL A. — SVP, Ops&Adm/Chief Legal Ofr
Oct 2, 2026
Sale
Shares
34
Price
$18.14
Total Value
$616.76
Shares Held After
270,517
% of Holdings
0.0%

SI-BONE, Inc. (SIBN)

PISETSKY MICHAEL A. — SVP, Ops&Adm/Chief Legal Ofr
Oct 2, 2026
Sale
Shares
1,799
Price
$18.14
Total Value
$32.64K
Shares Held After
270,551
% of Holdings
0.7%

SI-BONE, Inc. (SIBN)

PISETSKY MICHAEL A. — SVP, Ops&Adm/Chief Legal Ofr
Oct 2, 2026
Sale
Shares
1,300
Price
$18.20
Total Value
$23.66K
Shares Held After
272,350
% of Holdings
0.5%

SI-BONE, Inc. (SIBN)

Maheshwari Anshul — Chief Op&Financial Officer
Oct 2, 2026
Sale
Shares
1,758
Price
$18.19
Total Value
$31.98K
Shares Held After
219,966
% of Holdings
0.8%

SI-BONE, Inc. (SIBN)

Maheshwari Anshul — Chief Op&Financial Officer
Oct 2, 2026
Sale
Shares
1,560
Price
$18.17
Total Value
$28.34K
Shares Held After
221,724
% of Holdings
0.7%

ImmunityBio, Inc. (IBRX)

Cohen Cheryl — Director
Oct 2, 2026
Sale
Shares
81,056
Price
$10.50
Total Value
$851.09K
Shares Held After
100,309
% of Holdings
44.7%
Oct 2, 2026
Sale
Shares
786
Price
$21.00
Total Value
$16.51K
Shares Held After
13,578
% of Holdings
5.5%
Oct 2, 2026
Sale
Shares
558
Price
$20.72
Total Value
$11.56K
Shares Held After
80,484
% of Holdings
0.7%
Oct 2, 2026
Sale
Shares
797
Price
$21.17
Total Value
$16.87K
Shares Held After
23,087
% of Holdings
3.3%
Oct 2, 2026
Sale
Shares
3,431
Price
$3.47
Total Value
$11.91K
Shares Held After
15,782
% of Holdings
17.9%
Oct 2, 2026
Sale
Shares
6,167
Price
$3.47
Total Value
$21.40K
Shares Held After
597,504
% of Holdings
1.0%

Butterfly Network, Inc. (BFLY)

Carlson Megan — CAO and SVP, Finance
Oct 2, 2026
Sale
Shares
10,114
Price
$8.74
Total Value
$88.45K
Shares Held After
401,971
% of Holdings
2.5%

BICYCLE THERAPEUTICS PLC (BCYC)

Skynner Michael — CHIEF SCIENTIFIC OFFICER
Oct 2, 2026
Sale
Shares
1,942
Price
$3.47
Total Value
$6.74K
Shares Held After
155,229
% of Holdings
1.2%

BICYCLE THERAPEUTICS PLC (BCYC)

Perry Jennifer Scott — Chief Operating Officer
Oct 2, 2026
Sale
Shares
1,094
Price
$3.47
Total Value
$3.80K
Shares Held After
89,958
% of Holdings
1.2%

BICYCLE THERAPEUTICS PLC (BCYC)

Hannay Michael Charles Ferguson — CHIEF PROD&SUPPLY CHAIN OFF
Oct 2, 2026
Sale
Shares
1,572
Price
$3.47
Total Value
$5.45K
Shares Held After
92,803
% of Holdings
1.7%

OCULAR THERAPEUTIX, INC (OCUL)

Heier Jeffrey S. — Chief Scientific Officer
Oct 2, 2026
Sale
Shares
10,869
Price
$7.05
Total Value
$76.63K
Shares Held After
307,457
% of Holdings
3.4%

OCULAR THERAPEUTIX, INC (OCUL)

Kaiser Peter — Chief Development Officer
Oct 2, 2026
Sale
Shares
9,990
Price
$7.05
Total Value
$70.43K
Shares Held After
254,388
% of Holdings
3.8%
Oct 2, 2026
Sale
Shares
17
Price
$307.74
Total Value
$5.23K
Shares Held After
31,854
% of Holdings
0.1%
Oct 2, 2026
Sale
Shares
235
Price
$307.19
Total Value
$72.19K
Shares Held After
31,871
% of Holdings
0.7%
Oct 2, 2026
Sale
Shares
404
Price
$306.18
Total Value
$123.70K
Shares Held After
32,106
% of Holdings
1.2%
Oct 2, 2026
Sale
Shares
1,535
Price
$304.52
Total Value
$467.43K
Shares Held After
32,510
% of Holdings
4.5%
Oct 2, 2026
Sale
Shares
1,976
Price
$303.54
Total Value
$599.80K
Shares Held After
34,045
% of Holdings
5.5%
Oct 2, 2026
Sale
Shares
833
Price
$302.51
Total Value
$251.99K
Shares Held After
36,021
% of Holdings
2.3%
Oct 2, 2026
Purchase
Shares
2,500
Price
$16.00
Total Value
$40.00K
Shares Held After
27,000
% of Holdings
9.3%

ALNYLAM PHARMACEUTICALS, INC. (ALNY)

SUPRAN BRYAN — EVP, CLO and Secretary
Oct 2, 2026
Sale
Shares
1,758
Price
$226.88
Total Value
$398.86K
Shares Held After
12,807
% of Holdings
12.1%

BICYCLE THERAPEUTICS PLC (BCYC)

Thompson Travis Alvin — Chief Financial Officer
Oct 2, 2026
Sale
Shares
893
Price
$3.47
Total Value
$3.10K
Shares Held After
64,528
% of Holdings
1.4%

Intellia Therapeutics, Inc. (NTLA)

Dube Michael P — VP, Chief Accounting Officer
Oct 2, 2026
Sale
Shares
1,864
Price
$12.43
Total Value
$23.17K
Shares Held After
65,022
% of Holdings
2.8%
Oct 2, 2026
Purchase
Shares
100,000
Price
$8.57
Total Value
$857.24K
Shares Held After
314,000
% of Holdings
31.8%
Oct 2, 2026
Purchase
Shares
236,354
Price
$7.78
Total Value
$1.84M
Shares Held After
12,129,925
% of Holdings
1.9%
Oct 2, 2026
Sale
Shares
11,881
Price
$28.13
Total Value
$334.21K
Shares Held After
377,802
% of Holdings
3.0%
Oct 2, 2026
Sale
Shares
5,147
Price
$116.58
Total Value
$600.06K
Shares Held After
3,946
% of Holdings
56.6%
Oct 2, 2026
Sale
Shares
2,086
Price
$115.73
Total Value
$241.41K
Shares Held After
9,093
% of Holdings
18.7%
Oct 2, 2026
Sale
Shares
1,100
Price
$114.52
Total Value
$125.97K
Shares Held After
11,179
% of Holdings
9.0%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Oct 2, 2026
Sale
Shares
8,744
Price
$116.55
Total Value
$1.02M
Shares Held After
9,938
% of Holdings
46.8%

CORCEPT THERAPEUTICS INC (CORT)

Maduck Sean — President, Corcept Endocrinology The power of attorney under which this form was signed is on file with the Commission.
Oct 2, 2026
Sale
Shares
15,843
Price
$116.12
Total Value
$1.84M
Shares Held After
18,682
% of Holdings
45.9%

CORCEPT THERAPEUTICS INC (CORT)

Lyon Joseph Douglas — Chief Accounting&Technology Officer
Oct 2, 2026
Sale
Shares
4,744
Price
$116.54
Total Value
$552.87K
Shares Held After
5,683
% of Holdings
45.5%

CORCEPT THERAPEUTICS INC (CORT)

Lyon Joseph Douglas — Chief Accounting&Technology Officer
Oct 2, 2026
Sale
Shares
4,446
Price
$115.70
Total Value
$514.39K
Shares Held After
10,427
% of Holdings
29.9%

Immunovant, Inc. (IMVT)

Venker Eric — Director
Oct 2, 2026
Sale
Shares
3,506
Price
$34.11
Total Value
$119.59K
Shares Held After
257,075
% of Holdings
1.3%
Oct 2, 2026
Purchase
Shares
16,575
Price
$3.88
Total Value
$64.24K
Shares Held After
2,764,610
% of Holdings
0.6%
Version: v26.10.12